High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer.

Among patients who developed distant metastasis, those with FOXA1-high tumors had significantly longer DFS. We believe our data to raise the possibility of FOXA1 being a useful predictive marker for late recurrence and to provide new insights into the biology of FOXA1-high breast cancers.